Eggermont

Full Professor

Biography

lid raad van bestuur	Prinses Maxima Centrum voor Kinderoncologie	1-10-2019
adviseur	CCCMünchen	1-1-2022
adviseur	Deutsche Krebshilfe	1-9-2019
adviseur	DKFZ-Heidelberg	1-1-2020
Editor-in-chief	Eur J Cancer	1-1-2020
chairman board	Fondation Cancer, B	1-1-2015
member	DSMB Melanoma Trials NKI-AvL	1-1-2018
board member	SAB Ludwig Cancer Inst Lausanne	1-1-2022
board member	EORTC Foundation Board	1-1-2011
IDMCimmuno member	IKR/AvL	1-1-2021
Advisory board	Agenus	1-1-2021
Advisory board/DSMB	Biocad	1-1-2020
Advisory board	BioInvent	1-1-2020
IDMC	BioNTech	1-1-2020
Advisory board	CatalYm	1-1-2022
Advisory board	Clover	1-1-2017
Advisory board	Ellipses	1-9-2021
Advisory board	Galecto	1-1-2019
Advisory board/IDMC	GSK	1-1-2020
Advisory board	IO Biotech	1-2-2022
Advisory board	Merck	1-1-2019
IDMC	Pfizer	1-6-2019
Advisory board	Sairopa	1-6-2021
Advisory board	Sellas	1-1-2018
Advisory board	SkylineDx	1-1-2020
Advisory board	TigaTx	1-7-2021
Advisory board	TTxDiscovery	1-10-2021
Lezingen Melanoma	Biocad, BMS, MSD	1-1-2021

Contact

aeggerm3@umcutrecht.nl

Pure profile

Recent publications

All publications

Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice Axel Hauschild, Claus Garbe, Paolo Antonio Ascierto, Lev Demidov, Brigitte Dreno, Reinhard Dummer, Alexander Eggermont, Ana Maria Forsea, Christoffer Gebhardt, Jeffrey E. Gershenwald, Omid Hamid, Christoph Hoeller, Lidija Kandolf, Roland Kaufmann, John M. Kirkwood, Celeste Lebbé, Georgina V. Long, Josep Malvehy, Salvador Martin-Algarra, Grant McArthur, Bart Neyns, Erika Richtig, Caroline Robert, Dirk Schadendorf, Richard Scolyer, Vernon K. Sondak, Alberto Wainstein, Michael Weichenthal, Paolo Nuti,
The Lancet Oncology, 2025, vol. 26, p.12-14

European consensus-based interdisciplinary guideline for melanoma. Part 1 Claus Garbe, Teresa Amaral, Ketty Peris, Axel Hauschild, Petr Arenberger, Nicole Basset-Seguin, Lars Bastholt, Veronique Bataille, Lieve Brochez, Veronique del Marmol, Brigitte Dréno, Alexander M.M. Eggermont, Maria Concetta Fargnoli, Ana Maria Forsea, Christoph Höller, Roland Kaufmann, Nicole Kelleners-Smeets, Aimilios Lallas, Celeste Lebbé, Ulrike Leiter, Caterina Longo, Josep Malvehy, David Moreno-Ramirez, Paul Nathan, Giovanni Pellacani, Philippe Saiag, Eggert Stockfleth, Alexander J. Stratigos, Alexander C.J. Van Akkooi, Ricardo Vieira, Iris Zalaudek, Paul Lorigan, Mario Mandala,
European Journal of Cancer, 2025, vol. 215

The future of targeting cytotoxic T-lymphocyte-associated protein-4 Anna Maria Di Giacomo, Michael Lahn, Comprehensive Center München, Munich, Germany, Bernard Fox, Ramy Ibrahim, Padmanee Sharma, James P. Allison, Michele Maio
European Journal of Cancer, 2024, vol. 198

Capturing the true effect of anti-PD-1 therapy on patients’ health-related quality of life Emanuel Bührer, Michal Kicinski, Madeline Pe, Corneel Coens, Alexander M.M. Eggermont
The Lancet Oncology, 2024, vol. 25

The Role of CDCA2 in tumor genesis, prognosis and future treatments Xinyi Lin, Zijian Zou, Jingqin Zhong, Tong Wang, Wenjie Ma, Tu Hu, Wei Sun, Yu Xu, Alexander M.M. Eggermont, Yong Chen
European Journal of Cancer, 2024, vol. 211

Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial Alexander MM Eggermont, Michal Kicinski, Christian U. Blank, Mario Mandala, Georgina V. Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Marye Boers-Sonderen, Anna Maria Di Giacomo, Alfonsus JM van den Eertwegh, Jean Jacques Grob, Ralf Gutzmer, Rahima Jamal, Alexander C.J. van Akkooi, Paul Lorigan, Dmitri Grebennik, Clemens Kreplere, Sandrine Marreaud, Stefan Suciu, Caroline Robert
European Journal of Cancer, 2024, vol. 211

External positions

Lid SAB - Adviseren - Institut Jules Bordet

Lid SAB - Adviseren - EuroBio

Member Board - Adviseren - Trained Immunity Discovery

Lid IDMC - Adviseren - IQVIA

Lid IDMC - Adviseren - Pfizer

Lid SAB - Adviseren - IO Biotech

CMO - CMO - SAIROPA BV

Lid IDMC - Adviseren - Boehringel Ingelheim

Lid IDMC (independent data monitoring committee) - Adviseren - BioNTech

Voorzitter Steering Committee en Voorzitter Vorstand - Besturen en adviseren - Comprehensive Cancer Center Munich

Lid SAB - Adviseren - CatalYm

Lid SAB (Scientific adboard) - Lid SAB - BIOINVENT

Adviseur Trials - Adviseur Trials - Merck & Co and MSD Europe/NL

Voorzitter - Charity bestuur voorzitten/adviseren - FOCA (FOndation CAncer)

CMO - Adviseren - Skyline DX BV

Coordinator Comprehensive Cancer Center Program - Audits - Deutsche Krebshilfe

Lid Raad van Toezicht - Adviseren - EORTC

President 2014-2019 / Member Steering Cie 2019-2024 - Adviseren, Policy making - European Academy Cancer Sciences (EACS)